Here are the results after Barclays Capital analyst Alex Sloane’s intensive analysis of the Symrise paper.
The British investment bank Barclays has left Symrise at “Equal Weight” with a target price of 81 euros after quarterly figures. Thanks to the volume development, the organic sales decline of the flavors and fragrances manufacturer is better than expected and forecast by the company, wrote Alex Sloane in his first reaction on Wednesday. Symrise has confirmed the growth and margin targets for 2026. In the second half of the year, the comparable values from the previous year were lower, which ensured confidence.
Analysis and share valuation: An examination of the Symrise share at the time of the analysis
In XETRA trading, Symrise shares gained 6.1 percent at 12:42 p.m. The security therefore still has a scope for increase of 3.95 percent based on the set price mark. So far, 255,417 Symrise shares have changed hands in XETRA trading. Since the beginning of 2026, Symrise shares have climbed 13.1 percent. The Q2 2026 key figures are expected to be presented on July 30, 2026.
LONDON (dpa-AFX Analyzer) / editorial team finanzen.net
Publication of the original study: April 29, 2026 / 06:30 / GMT First distribution of the original study: April 29, 2026 / 06:31 / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 Para. 1 WpHG, Art. 20 Regulation (EU) 596/2014 for the analyst firm mentioned can be found at http://web.dpa-afx.de/offenlegenspflicht/offenlegens_pflicht.html.
Selected leverage products on Symrise
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Symrise
The leverage must be between 2 and 20
Advertising
